LABORATOIRES EUROMEDISLABORATOIRES EUROMEDISLABORATOIRES EUROMEDIS

LABORATOIRES EUROMEDIS

No trades
See on Supercharts
Market capitalization
‪11.44 M‬EUR
‪2.74 M‬
Beta (1Y)
−0.03

About LABORATOIRES EUROMEDIS


CEO
Mathieu Roturier
Headquarters
Neuilly-sous-Clermont
Founded
1996
ISIN
FR0000075343
FIGI
BBG000BS2645
Laboratoires Euromedis SA specializes in the design, manufacturing, and distribution of medical equipment. Its products include disposable medical gloves, surgical items, hygiene and protection equipment, needles, syringes, transfusion equipment, compresses, bandages, and beds. The company was founded by Jean-Pierre Roturier on April 22, 1996 and is headquartered in Neuilly-sous-Clermont, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ALEMG is 4.38 EUR — it has decreased by −1.35% in the past 24 hours. Watch LABORATOIRES EUROMEDIS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange LABORATOIRES EUROMEDIS stocks are traded under the ticker ALEMG.
ALEMG stock has fallen by −1.35% compared to the previous week, the month change is a −4.78% fall, over the last year LABORATOIRES EUROMEDIS has showed a −14.79% decrease.
We've gathered analysts' opinions on LABORATOIRES EUROMEDIS future price: according to them, ALEMG price has a max estimate of 4.00 EUR and a min estimate of 4.00 EUR. Watch ALEMG chart and read a more detailed LABORATOIRES EUROMEDIS stock forecast: see what analysts think of LABORATOIRES EUROMEDIS and suggest that you do with its stocks.
ALEMG reached its all-time high on Feb 27, 2020 with the price of 28.40 EUR, and its all-time low was 3.56 EUR and was reached on Dec 2, 2019. View more price dynamics on ALEMG chart.
See other stocks reaching their highest and lowest prices.
ALEMG stock is 1.60% volatile and has beta coefficient of −0.03. Track LABORATOIRES EUROMEDIS stock price on the chart and check out the list of the most volatile stocks — is LABORATOIRES EUROMEDIS there?
Yes, you can track LABORATOIRES EUROMEDIS financials in yearly and quarterly reports right on TradingView.
ALEMG net income for the last half-year is ‪−532.00 K‬ EUR, while the previous report showed ‪−5.57 M‬ EUR of net income which accounts for 90.44% change. Track more LABORATOIRES EUROMEDIS financial stats to get the full picture.
No, ALEMG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALEMG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LABORATOIRES EUROMEDIS stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LABORATOIRES EUROMEDIS technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LABORATOIRES EUROMEDIS stock shows the sell signal. See more of LABORATOIRES EUROMEDIS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.